Reinhard Schneppenheim

This inventor holds 4 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: Siemens Healthcare Diagnostics Products Gmbh. Active years: 2015-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reinhard Schneppenheim. Retrieved from https://idiyas.com/inventor/reinhard-schneppenheim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 10(Granted Patents)

Company Filing History:

4 out of 107

Siemens Healthcare Diagnostics Products Gmbh

patents

Years Active: 2015-2020

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10591490 - Methods and kits for determining von willebrand factor activity in the absence of ristocetin (2020-03-17),

2. 9869683 - Methods and kits for determining von Willebrand factor activity in the absence of ristocetin (2018-01-16),

3. 9222942 - Methods and kits for determining von willebrand factor activity in the absence of ristocetin (2015-12-29),

4. 8932820 - Methods and kits for determining von Willebrand factor activity in the absence of ristocetin and for determining the activity of ADAMTS-13 protease (2015-01-13),

Title: Reinhard Schneppenheim: Innovator in Hematology

Introduction

Reinhard Schneppenheim is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of hematology, particularly in the study and determination of von Willebrand factor activity. With a total of 4 patents to his name, his work has had a substantial impact on medical diagnostics.

Latest Patents

Schneppenheim's latest patents include innovative methods and kits for determining von Willebrand factor activity in the absence of ristocetin. These patents describe various methods, kits, and reagents designed to accurately assess von Willebrand factor (VWF) activity in samples without the need for ristocetin, enhancing diagnostic capabilities in clinical settings.

Career Highlights

Reinhard Schneppenheim is associated with Siemens Healthcare Diagnostics Products GmbH, where he applies his expertise to develop advanced diagnostic solutions. His work has been instrumental in improving the understanding and management of bleeding disorders related to von Willebrand factor.

Collaborations

Some of his notable coworkers include Harald Althaus and Tobias Obser, with whom he has collaborated on various projects aimed at advancing hematological diagnostics.

Conclusion

Reinhard Schneppenheim's contributions to the field of hematology through his patents and work at Siemens Healthcare Diagnostics Products GmbH highlight his role as an innovator in medical diagnostics. His efforts continue to influence the way von Willebrand factor activity is assessed, ultimately benefiting patient care.

Profile summary based on public USPTO records.